We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Molecular Partners Ag | LSE:0QXX | London | Ordinary Share | CH0256379097 | MOLECULAR PARTNERS ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 25.20 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
2,259 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 7.04M | -61.98M | -1.7050 | -14.78 | 916.12M |
Date | Time | Source | Headline |
---|---|---|---|
12/1/2025 | 18:00 | UKREG | Molecular Partners Outlines Clinical Expansion Plans and Strengthens.. |
12/1/2025 | 18:00 | UKREG | Molecular Partners and Orano Med expand partnership to develop Targeted.. |
17/12/2024 | 21:00 | UKREG | Molecular Partners to Present at JP Morgan Healthcare Conference and Baader.. |
08/12/2024 | 17:00 | UKREG | Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533.. |
07/11/2024 | 21:00 | UKREG | Molecular Partners Presents Preclinical Proof-of-Concept for CD3.. |
05/11/2024 | 21:00 | UKREG | Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH.. |
31/10/2024 | 20:00 | UKREG | Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates.. |
25/10/2024 | 05:00 | UKREG | Molecular Partners Announces Pricing of $20 Million Underwritten Offering |
22/10/2024 | 05:00 | UKREG | Molecular Partners and Orano Med Strengthen Agreement to Co-Develop.. |
22/10/2024 | 05:00 | UKREG | Molecular Partners and Orano Med Present Additional Positive Preclinical.. |
1 Year Molecular Partners Chart |
Intraday Molecular Partners Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions